Healthcare - Medical - Devices - NASDAQ - US
$ 11.95
-5.01 %
$ 313 M
Market Cap
-5.36
P/E
Price Target
Average
--24.69%
Revenue Forecast
Estimate
66.40%
EBIT
Estimate
--82.61%
Net Income
Estimate
78.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AVITA Medical, Inc.
Wall Street analysts predict an average 1-year price target for RCEL of $9 , with forecasts ranging from a low of $9 to a high of $9 .
RCEL Lowest Price Target
Wall Street Target
9 USD
-24.69%
RCEL Average Price Target
Wall Street Target
9 USD
-24.69%
RCEL Highest Price Target
Wall Street Target
9 USD
-24.69%
REVENUE FORECAST
Revenue Forecast Chart RCEL
EBIT FORECAST
EBIT Forecast Chart RCEL
NET INCOME FORECAST
Net Income Chart RCEL